Mylotarg
NDC 0008-4510, gemtuzumab ozogamicin, injection, powder, lyophilized, for solution, from Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc..
- Product NDC
- 0008-4510
- Status
- Listed
- Labeler
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761060
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0008-4510 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GEMTUZUMAB OZOGAMICIN5 mg/5mL
Pharmacologic classes
CD33-directed Antibody Interactions [MoA]; CD33-directed Immunoconjugate [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0008-4510-01 | 00008451001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0008-4510-01) / 5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/32fd2bb2-1cfa-4250-feb8-d7956c794e05Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0008-4510
Use it
Look up 0008-4510 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0008-4510 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0008-4510. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.